Header image

Concurrent Session 4A: Harm Reduction, Overdose & Drug Use Practices

Tracks
.
Wednesday, November 11, 2026
9:00 AM - 10:30 AM
Pleiades

Speaker

Agenda Item Image
Mr Paul Dessauer
Chief Executive Officer
Peer Based Harm Reduction WA

Introduction & Welcome

9:00 AM - 9:05 AM

Paul is CEO of Peer Based Harm Reduction WA (PBHR WA), Western Australia’s only peer-based consumer-led AOD service, which provides free health and harm reduction services for people who use drugs. Paul has worked at PBHR WA for >25 years, delivering and coordinating outreach services, overdose prevention, take-home-naloxone, and peer-education projects, while providing consultancy to researchers and policy makers and workforce development to other front-line agencies. Paul has previously worked as a Drug & Alcohol Officer for the State-wide Specialist Aboriginal Mental Health Service; an educator & consultant for the Transnational Institute (in China and Myanmar); and a trainer for the Burnet Institute. Paul is committed to addressing stigmatisation directed at, improving the health equity of, and promoting the fundamental human rights of, people who use drugs. In all his work Paul strives to bring the voices and living experience of people who use drugs to research, policy, and practice.
Agenda Item Image
A/Prof Thileepan Naren
Addiction Medicine Specialist
Western Health

Mobilising Harm Reduction services to adapt to changing population

9:05 AM - 9:15 AM

Abstract PDF

A/Prof Thileepan Naren is an Addiction Medicine Specialist and General Practitioner and has special interests in addiction medicine, Aboriginal health, custodial health, public health policy, and medical governance.
Agenda Item Image
Dr Jodie Grigg
Research Fellow
National Drug Research Institute, Curtin University

Patterns of polysubstance use during stimulant consumption sessions and self-reported non-fatal overdose events among people who regularly use ecstasy and other illicit stimulants in Australia

9:15 AM - 9:25 AM

Abstract PDF

Jodie is a Postdoctoral Research Fellow at NDRI where she is the long-standing coordinator of the Perth arm of the Ecstasy and Related Drugs Reporting System (EDRS). She has a strong interest in monitoring polysubstance use trends, drug-related harms, and harm reduction, particularly in music and event settings.
A/Prof Daniel Demant
Associate Professor in Social Epidemiology
Discipline of Public Health, University Of Technology Sydney

Understanding chemsex beyond risk: Psychosocial correlates and substance use patterns in Australia

9:25 AM - 9:35 AM

Abstract PDF

Daniel Demant is an Associate Professor of social epidemiology with a focuses substance use and sexual wellbeing, particularly in LGBTQ+ populations. His work aims at exploring the psychosocial and contextual drivers of risk and harm and the relationship between substance use and sexual wellbeing.
Agenda Item Image
Miss Grace Oh
Director
Australian Drug Education & Consultancy

Co-presenter: Innovative Harm Reduction: Disrupting the Homelessness Merry-Go-Round - Transitional Housing with Integrated Drug and Alcohol Treatment

9:35 AM - 9:45 AM

Abstract PDF

Grace Oh, AOD harm reductionist, is known for her optimism and commitment to advocacy and advancing equitable, person-centred initiatives across drug checking, naloxone, peer education, and treatment for people facing recurring homelessness. She is a Director of Australian Drug Education & Consultancy and WA APSAD Council representative.
Dr Courtney Weber
Data Manager For The Emerging Drugs Network Of Australia
Royal Perth Hospital

3,4-methylenedioxymethylamphetamine (MDMA) concentrations in Emergency Department presentations enrolled in the Emerging Drugs Network of Australia

9:45 AM - 9:55 AM

Abstract PDF

Courtney Weber is the Data Manager for the Emerging Drugs Network of Australia. Her interests are novel psychoactive substances and epidemiological methods.
Agenda Item Image
Dr Louisa Picco
Senior Research Fellow
Monash Addiction Research Centre, Monash University

Changes in naloxone attitudes and provision over the past decade: Findings from the National Drug Strategy Household Surveys and national community pharmacy surveys

9:55 AM - 10:05 AM

Abstract PDF

Dr Louisa Picco is an NHMRC Emerging Leader Research Fellow and the Drug Policy and Harm Reduction Program Lead at the Monash Addiction Research Centre. Her work adopts a multifaceted approach to explore the implementation and impact of opioid policies and harm reduction strategies.
Dr Hayden Green
GP and Addiction Medicine Trainee
Cohealth

Intranasal mucosal atomiser devices: a novel harm reduction intervention

10:05 AM - 10:10 AM

Abstract PDF

Hayden is a Fellow of the RACGP and a final year addiction medicine advanced trainee working in community health/primary care and harm reduction in Melbourne, Victoria.
Dr Kirrilly Thompson
Senior Research Fellow
NCETA

Barriers and enablers to take-home naloxone access in Australia: A scoping review

10:10 AM - 10:15 AM

Abstract PDF

Clinical pharmacy postdoctoral research fellow with expertise in medication use, cardiac rehabilitation, pharmacotherapy, and adherence. Holds a PhD in Clinical Pharmacy and has over 10 years’ experience across research, academia, and pharmacy practice in Australia and Ethiopia, with more than 25 peer-reviewed publications and multidisciplinary collaborations.
APSAD 2026

Session Q&A

10:15 AM - 10:30 AM


Chair

Agenda Item Image
Paul Dessauer
Chief Executive Officer
Peer Based Harm Reduction WA

loading